sulfobromophthalein has been researched along with Scleroderma, Systemic in 1 studies
Sulfobromophthalein: A phenolphthalein that is used as a diagnostic aid in hepatic function determination.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Backer, G | 1 |
| de Groote, J | 1 |
1 review available for sulfobromophthalein and Scleroderma, Systemic
| Article | Year |
|---|---|
[Systemic diseases and liver involvement: a review].
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Biopsy; Collagen Diseases; Dermatomyositis; Galactose; H | 1972 |